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Abstract: In newborns, severe congenital heart defects are rarer than mild ones. This epidemiological
relationship between heart defect severity and incidence lacks explanation. Here, an analysis of
~10,000 Nkx2-5+/− mice from two inbred strain crosses illustrates the fundamental role of epistasis.
Modifier genes raise or lower the risk of specific defects via pairwise (G×GNkx) and higher-order
(G×G×GNkx) interactions with Nkx2-5. Their effect sizes correlate with the severity of a defect. The
risk loci for mild, atrial septal defects exert predominantly small G×GNkx effects, while the loci
for severe, atrioventricular septal defects exert large G×GNkx and G×G×GNkx effects. The loci for
moderately severe ventricular septal defects have intermediate effects. Interestingly, G×G×GNkx
effects are three times more likely to suppress risk when the genotypes at the first two loci are from
the same rather than different parental inbred strains. This suggests the genetic coadaptation of
interacting G×G×GNkx loci, a phenomenon that Dobzhansky first described in Drosophila. Thus,
epistasis plays dual roles in the pathogenesis of congenital heart disease and the robustness of cardiac
development. The empirical results suggest a relationship between the fitness cost and genetic
architecture of a disease phenotype and a means for phenotypic robustness to have evolved.
Keywords: congenital heart defects; quantitative trait loci; modifier genes; genetic epistasis
1. Introduction
Congenital heart disease (CHD) is recognized as the most common birth defect, but
cardiac malformation actually encompasses anatomically distinct phenotypes in which
the severity and incidence of a defect are inversely related. For example, secundum atrial
septal defects (ASD), which are compatible with survival into middle age, are three times
more common than atrioventricular septal defects (AVSD), which can cause death during
infancy (Figure 1a) [1,2]. No simple or single hypothesis explains the epidemiological
relationship, such as a genotype–phenotype correlation or a lower frequency of the causes
of severe defects. Furthermore, the fetoplacental circulation enables severe defects to be
compatible with survival to birth. The inverse relationship does suggest that each defect
has a liability threshold related to its fitness cost: the higher the threshold, the rarer a defect
is. In other words, the developmental pathways that lead to a severe defect are more robust
to perturbation than the ones to a mild defect.
Questions regarding how the fitness cost of a defect relates to the robustness of
the underlying pathways are practical and fundamental. An appreciation of the genetic
architecture of a heart defect—i.e., the genes involved, alleles, interactions, and their
effects—could inform genetic risk models and strategies for prevention. The genetic
architecture encompasses more than the proximate cause of disease. As a rule, the same
deleterious mutation in different individuals can manifest as a mild, moderate, or severe
Genes 2021, 12, 1368. https://doi.org/10.3390/genes12091368 https://www.mdpi.com/journal/genes
Genes 2021, 12, 1368 2 of 14
defect or no defect at all. The relationship holds in general for causes of syndromic and
isolated CHD. For example, despite the well-known associations of trisomy 21 and 22q11.2
deletion with atrioventricular septal defects and tetralogy of Fallot, respectively, their
most common cardiac phenotypes are structurally normal heart or an atrial or ventricular
septal defect [3,4]. Likewise, the NKX2-5 mutation, which causes isolated CHD, is most
commonly associated with atrial septal defects, although severe defects such as tetralogy
of Fallot and double outlet right ventricle were reported [5,6].
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Figure 1. The severity and incidence of a heart defect are negatively correlated. (a) In humans, mild 
defects are more common than severe ones. The median survival without surgical intervention de-
fines the severity of a defect [2]. The panels show representative heart defects from Nkx2-5+/− pups. 
Arrows point to a secundum ASD, membranous and muscular VSDs, and the common atrioventric-
ular canal in an AVSD. (b) As in humans, the incidences of heart defects in Nkx2-5+/− newborns are 
inversely related with their severity (Kendall’s partial rank correlation  = −0.845, P < 0.01). Double 
outlet right ventricle (DORV) was present in 18 and 3 Nkx2-5+/− hearts from the F×B and A×B inter-
crosses, respectively. One case of tricuspid atresia was found in each intercross. 
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the modifier QTLs in the F2 intercross of A×B and in the combined F2 and advanced in-
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The number of detected loci is similar between the four heart defects (Figure S2a). 
G×GNkx effect sizes, however, vary with the severity of a defect. G×GNkx interactions have 
a small effect on ASD risk and increasingly larger effects for VSDs and AVSD. The corre-
lation holds whether the effect is calculated as the risk associated with a susceptibility 
Figure 1. The severity and incidence of a heart defect are negatively correlated. (a) In humans, mild
defects are more co on t The median survival without surgical intervention
defines the severity of a defect [2]. The panels show representative heart defects from Nkx2-5+/−
pups. Arrows point to a secundum ASD, membranous and muscular VSDs, and the common
atrioventricular canal in an AVSD. (b) As in humans, the incidences of heart defects in Nkx2-5+/−
newborns are inversely related with their severity (Kendall’s partial rank correlation τ = −0.845,
P < 0.01). Double outlet right ventricle (DORV) was present in 18 and 3 Nkx2-5+/− hearts from the
F×B and A×B intercrosses, respectively. One case of tricuspid atresia was found in each intercross.
Modifier genes affect the phenotypic outcome [7]. Genetic heterogeneity and rare
alleles, however, hamper the detection of epistasis in humans and the elucidation of
complex genetic principles. Inbred strain crosses in mutant mouse models can circumvent
these limitations. The number of alleles at a locus is limited to two, and the frequencies of
both alleles can be kept equally common.
Inbred str in crosses of Nkx2-5+/− mice, a model of non-syndromic human CHD,
demonstrate that the incidence of specific defects can vary betwe genetic back ounds [8].
We previ usly began two seri s of inbred strain crosses to e tablish gener conclusio s
that would not be unique to one cr ss. F rst-generation (F1) hybrids of the inbred strains
C57BL/6N and FVB/N or A/J were found to have a lower incidence of congenital he rt
defects than Nkx2-5+/− mice in the C57BL/6N background or the second-ge eration (F2)
offspring of backcrosses to the parental strains or intercrosses (F1×F1). The results suggest
a role in CHD genetics for h erosis, a well-described phenome on in agricultural genetics
in which heterozygo ity acros the g nome increases the average level of robustness in a
population [8]. Furthermore, these and th r cr sses de onstrate that genetic interactions
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modulate the robustness of specific cardiac developmental pathways to Nkx2-5 mutation
and hence the risks of anatomically distinct malformations [9,10].
Epistasis contributes quantifiably to fitness traits in simple organisms, such as yeast [11],
Drosophila [12], and C. elegans [13]. On the other hand, quantitative evidence for a contribu-
tion of epistasis in higher organisms is scant, and theoretical analyses arrive at disparate
conclusions regarding the significance of epistasis in complex traits and disease [14,15].
Why the results conflict is hotly debated [16]. One reason pertinent to congenital heart dis-
ease is that the contribution of epistasis could vary with the fitness cost of a phenotype [15].
Natural selection indisputably eliminates deleterious mutations, but selection may also
increase the robustness of pathways to perturbation by shaping genetic interactions and
networks [17].
We reasoned that a comparative analysis of the genetic architecture of four CHD
phenotypes caused by the same mutation could illuminate the subject. The four defects—
ASD, muscular and membranous ventricular septal defects (VSD), and AVSD—have mild
to severe fitness costs, as defined by the likelihood of survival to reproductive age in
humans [2]. We determined the number and effects of quantitative trait loci (QTLs) on
the risk of each heart defect in Nkx2-5+/− mice from two different inbred strain crosses.
Each QTL represents a pairwise interaction between a modifier gene and Nkx2-5 (G×GNkx).
In addition, we examined the non-linear effects of higher-order interactions between two
QTLs and Nkx2-5 (G×G×GNkx). Empirical data are sorely required regarding the nature of
genetic risk in CHD. More fundamentally, a quantitative analysis of epistasis in a set of
phenotypes with varying fitness costs could inform a longstanding debate regarding the
origins of mutational robustness [18].
2. Materials and Methods
2.1. Mouse Strains and Crosses
Inbred C57BL/6N (B) and FVB/N (F) mice were purchased from Charles River (Wilm-
ington, Massachusetts) and A/J (A) from the Jackson Laboratory (Bar Harbor, Maine). Mice
were housed under standard conditions in the same room with access to water and chow ad
libitum. The Nkx2-5+/− mutant line was maintained in the C57BL/6N background [8,19].
To produce F1 hybrids, Nkx2-5+/− C57BL/6N males were crossed to wild-type A/J or
FVB/N females. The Nkx2-5+/− F1 was then crossed to produce A×B and F×B F2 progeny.
We also produced F10 and F14 advanced intercross generations of F×B by random mating
from the F2 generation onward. No matings between siblings or first cousins were allowed
from the F3 and F4 generations onward [20]. Breeder mice were selected at random; they
presumably had no significant congenital heart defect by virtue of their healthy appearance
and reproductive fitness. The decision to develop the advanced intercross in F×B rather
than A×B was arbitrary. An advanced intercross of A×B was not pursued because of
resource constraints.
2.2. Collection and Phenotyping of Hearts
We collected and phenotyped hearts as previously described [8]. Briefly, pups were
collected within hours of birth. Thoraxes were fixed in 10% neutral buffered formalin.
After Nkx2-5 genotyping, all Nkx2-5+/− and a subset of wild-type hearts were dissected
and embedded in paraffin. Hearts were completely sectioned in the frontal plane at 6 µm
thickness. Every section was collected, stained with hematoxylin and eosin, and evaluated
by two individuals. Defects were diagnosed by the morphology of the atrial and ventricular
septae, semilunar and atrioventricular valves, chambers, and the anatomic relationships
between them. Secundum ASDs were distinguished from a patent foramen ovale based on
the size of the latter in wild-type hearts.
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2.3. Single Nucleotide Polymorphism Genotyping
Genomic DNA was isolated by phenol–chloroform extraction. SNP genotyping was
performed on affected and normal Nkx2-5+/− mice. In the F×B advanced intercross, normal
controls were randomly selected from unaffected siblings.
The A×B and F×B F2 intercrosses were genotyped using custom panels of ~120 SNPs
on the Sequenom MassARRAY system [10]. The average distance between markers was
19–24 Mb. The F×B advanced intercross generations were genotyped on the Mouse MD
Linkage Panel (Illumina, San Diego, CA). A subset of 761 SNPs on the panel was selected for
subsequent analyses. We eliminated SNPs that had >10% missing genotypes or low median
quality scores (GC < 0.35) or were not in dbSNP (build 141). Fewer SNPs were genotyped
in the F2 than the advanced intercross generations because there is less recombination.
Combining SNPs from the F×B F2 and advanced intercrosses yielded 887 markers spaced
an average of 3 Mb apart. SNP locations were assigned according to GRCm38/mm10.
The sex chromosomes were not analyzed. Table S1 lists the SNPs and their minor allele
frequencies in each cross.
2.4. Genetic Imputation and Association Analyses
QTLs that modify the risk of a heart defect were mapped via case-control association
tests. Each type of heart defect was analyzed separately. The same normal controls were
used in each analysis.
We utilized R/qtl (version 1.40-8) to map QTLs under a binary trait model in the A×B
F2 intercross [21]. Permutation testing (N = 5000) was performed to determine significance
thresholds. Significant and suggestive loci had LOD scores >3.3 (α = 0.05) and >2.7 (α = 0.2),
respectively.
We implemented a univariate linear mixed model in GEMMA (version 0.94.1) for a
combined analysis of the F×B F2 and advanced intercross generations [22]. A likelihood
ratio test compared the alternative hypothesis that an SNP has a non-zero effect against the
null hypothesis of zero effect. Each binary phenotype was modeled as a function of SNP
genotypes and a random or polygenic effect that accounts for relatedness (Equation (1)):
y = µ+ xβ+ u + ε (1)
where y is the vector of binary phenotypes (0 = control, 1 = heart defect), µ is the mean, x is
a vector of SNP marker genotypes, β is a vector of marker effects, u is a vector of random
effects, and ε is a vector of errors. Genome-wide significance thresholds were Bonferroni
corrected. The effective number of tests was 542 after accounting for linkage between
SNPs [23,24]. Significant and suggestive loci had nominal P values < 9.2 × 10−4 (0.05/542)
and <1.8 × 10−3 (1/542). The combined analysis of the F2 and advanced intercross
generations enhances the resolution of mapping but poses two special considerations [25].
First, some SNPs were not genotyped in either the F×B F2 or advanced intercross
generations and were imputed. In the F2, 758 SNPs were imputed using R/qtl [21]. In the
advanced intercross, 126 SNPs were imputed using QTLRel (version 0.2–15). The F10 and
F14 were imputed separately because of differences in recombination patterns between the
generations [26]. We estimated that >80% of missing genotypes in the F2 were imputed
with >70% confidence; only 2% were imputed with less than 50% confidence. For the
advanced intercross generations, 99.9% of missing genotypes were imputed with >70%
confidence.
Second, to minimize type I error, we accounted for unequal relatedness between
individuals in the advanced intercross generations. The univariate linear mixed model,
Equation (1), incorporates a genetic relatedness matrix (GRM) that captures the phenotypic
variance due to the genome-wide similarity between individuals. For each case-control
analysis, we used GEMMA to estimate centered GRMs using the SNP genotypes from
the combined F×B generations. Because F2 individuals are essentially full siblings, their
pairwise relatedness coefficients were set to 0.5 and 1 on the diagonal in the GRM. We then
adjusted the entire matrix (F2 + advanced intercross generations) to the nearest positive
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definite matrix using the nearPD function in the “Matrix” R package (version 1.2-6). The
adjustment adds a small amount of noise to the GRM to remove negative eigenvalues,
which is necessary for the stability of the mixed model. A Mantel test for the similarity
between the pre- and post-adjusted GRMs showed >95% similarity in all cases.
2.5. Estimation of Heritability
The proportion of the phenotypic variance explained (PVE) by all genotyped SNPs
was estimated using restricted maximum likelihood (REML) in the linear mixed model in
GEMMA. This method uses the GRM to estimate the genome-wide PVE and its standard
error for each type of heart defect in the A×B and F×B intercrosses [27]. PVE estimates
were corrected for ascertainment bias and transformed to the liability scale (PVEl) according
to Equation (2):
PVEl = PVE ×
P2(1− P)2
A(1−A)z2 (2)
where P is the population disease incidence, A is the incidence in the ascertained cohort, and
z is the height of the standard normal distribution at the population liability threshold [28].
2.6. Analysis of G×GNkx Effects
The proportion of the phenotypic variance explained by an SNP, PVESNP, was calcu-





where MAF is the minor allele frequency, PV is the phenotypic variance, β is the effect
of the SNP as estimated in GEMMA for both the A×B and F×B intercrosses. PVESNP
estimates were corrected and transformed to the liability scale in the same manner as the
genome-wide PVE estimates.
We estimated the odds ratios for the G×GNkx effects using logistic regression models.
The odds ratios for each A×B locus were obtained using the base glm function in R. The
odds ratios for each F×B locus were obtained using the logistic mixed model implemented
in GMMAT [29]. The mixed model controlled for relatedness via the GRMs above.
2.7. Analysis of G×G×GNkx Effects
The contribution of higher-order epistatic effects to the risk of a heart defect was
calculated according to the physiological epistasis model [30]. The G×G×GNkx effect
is determined by the difference between the observed and the expected incidences of a
defect at a two-locus genotype under the null model of independently acting loci. The
expected incidence is calculated from the unweighted regression of the two-locus genotype
incidences onto the two single-locus incidences. To compare G×G×GNkx effects between
defects that have different incidences, the effects were divided by the unweighted average
incidence of the defect across all nine genotype combinations between two loci. Effects
that raise or lower risk are deemed positive or negative, respectively. To assess statistical
significance, we arcsine-transformed the effects to obtain unbiased variances [31]. Using
these variances, we conducted two-tailed T-tests to identify significant, non-zero effects.
The significance threshold was Bonferroni-corrected for the number of two-locus genotypes
in a pairwise analysis, i.e., P = 0.05/9x, where x is the number of pairwise combinations
of loci for a defect. To compare effects between defects that have different incidences, the
significant epistatic effects were divided by the unweighted average incidence of each
defect [30]. Because only one G×GNkx modifier locus was identified for ASD and muscular
VSD in the F × B population, we assessed G×G×GNkx effects in combination with the
next most significant SNP (ASD: rs13478997, Chr. 6, P = 1.94 × 10−3; muscular VSD:
gnf13.115.241, Chr. 13, P = 2.39 × 10−3.)
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2.8. Statistical Analyses
GEMMA was run on the Ubuntu operating system (version 14.04 LTS). All other sta-
tistical analyses were performed in the R Statistical Computing environment (version 3.3.1).
All t- and z-tests for comparisons of means and proportions, respectively, were two-sided.
We used the R package “ppcor” [32] to calculate Kendall’s (non-parametric) partial rank
correlation τ with a two-sided alternative hypothesis. Partial correlations permitted us to
calculate non-parametric correlation while controlling for the intercross and the sample
size [33,34]. For the partial correlation calculation of G×G×GNkx effects versus defect
severity (Figure 3e), we controlled for variation in the observed incidence at two-locus
genotypes to avoid bias by an underlying correlation.
3. Results
3.1. Nkx2-5+/− Mice Mimic the Epidemiological Relationship between the Severity and Incidence
of a Heart Defect
We phenotyped ~10,000 Nkx2-5+/− newborns from intercrosses between the inbred
strains A/J and C57BL/6N (A×B, N = 2999) and FVB/N and C57BL/6N (F×B; N = 6958).
An ASD is the most common defect associated with human NKX2-5 mutation [6,35]. An
ASD is also most common in the mouse crosses, followed by membranous and muscular
ventricular septal defects (VSD) and AVSD (Figure 1a). The two anatomic types of VSD
have different developmental bases but similar pathophysiological consequences. We note
this because epidemiological studies typically combine membranous and muscular VSDs,
making VSD appear more common than ASD [1]. Both intercrosses recapitulate the inverse
relationship between the severity and incidence of a heart defect (Figure 1b). The attrition
of more severely affected embryos does not explain the distribution of defects because
Nkx2-5+/− mice are born at the expected Mendelian ratio. In fact, we obtained pups with
very severe heart defects, such as double outlet right ventricle and tricuspid atresia, but too
few for quantitative genetic analysis. About 70% of Nkx2-5+/− mice from either intercross
have a normal heart.
3.2. The Effect of G×GNkx Interactions between a QTL That Modifies the Risk of a Defect and
Nkx2-5 Correlates with the Severity of the Defect
The total, quantitative effect of genetic modifiers on risk could be a function of the
number of genes, their effect sizes, or both. To distinguish these possibilities, we mapped
the modifier QTLs in the F2 intercross of A×B and in the combined F2 and advanced
intercross generations of F×B (Figure S1). Mapping in an F2 intercross has greater power
to detect loci, whereas the combined analysis of an F2 and later generations has greater
mapping resolution [20]. There were no rare alleles in either cross. The minor allele
frequency of SNPs was 0.481 ± 0.012 in the offspring of the A×B cross and 0.446 ± 0.036
in the F×B cross (mean ± s.d.). We mapped QTLs for ASD, membranous and muscular
VSD, and AVSD (Figure 2a, Table S2). Each set of QTLs represents G×GNkx interactions in
developmental pathways leading to a defect.
QTLs that overlap between defects may share a gene involved in the development
of multiple cardiac structures (Table S2). Overlapping A×B loci include ones on Chromo-
some 3 for ASD and AVSD, Chromosome 4 for ASD, membranous VSD and AVSD, and
Chromosome 8 for membranous and muscular VSD. Overlapping F×B loci include one on
Chromosome 6 for membranous and muscular VSD. An AVSD locus on chromosome 5, in
which B carries the risk allele, overlapped between the A×B and F×B crosses.
The number of detected loci is similar between the four heart defects (Figure S2a).
G×GNkx effect sizes, however, vary with the severity of a defect. G×GNkx interactions have
a small effect on ASD risk and increasingly larger effects for VSDs and AVSD. The correla-
tion holds whether the effect is calculated as the risk associated with a susceptibility allele
or the phenotypic variance explained by a locus (Figure 2b,c). To account for undetected
loci, we estimated the phenotypic variability, i.e., heritability, explained by all genotyped
SNPs. The heritability is similar between defects (Figure S2b). Therefore, the correlation
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between G×GNkx effect size and severity is not due to a larger total genetic contribution to
the risk of severe defects.
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Figure 2. The quantitative effect of G×GNkx interactions on risk correlates with the severity of a heart defect. (a) Genetic
loci modify the risk of specific heart defects in Nkx2-5+/− mice from the F×B and A×B intercrosses. The number of
affected Nkx2-5+/− newborns genotyped for each defect is indicated. Normal Nkx2-5+/− littermates were genotyped as
controls (N = 330 A×B and 1024 F×B). Suggestive and genome-wide significance thresholds are indicated in blue and red.
(b,c) G×GNkx effects on risk, quantified as the percent variance explained by the most significant SNP at a locus or the odds
ratio for each risk allele, correlate with defect severity. Muscular (triangle) and membranous (circle) VSD loci are analyzed
together because the two VSD types have similar severity. The hatch marks indicate the mean.
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3.3. The Effect of G×G×GNkx Interactions between Two QTLs and Nkx2-5 Correlates with the
Severity of a Defect
While each QTL was mapped according to its individual effect on risk, two loci may
interact. Representative examples compare the observed to the expected incidences at
two-locus genotypes under the null model of non-interacting loci [30]. Small differences
between the observed and expected incidences of ASD and VSD indicate that each locus
exerts mainly independent or additive effects (Figure 3a,b; Figure S3 shows the observed
incidences between the nine genotypes at all locus pairs). In contrast, the incidence of
AVSD at a two-locus genotype can deviate substantially from the null expectation, indicat-
ing a non-linear effect. Some differences are very large relative to the population or the
unweighted average incidence of a defect across the nine genotypes (Figure 3c,d). The un-
weighted average incidence permits comparisons between defects of higher-order epistatic
effects independently of genotype frequencies [30]. The population and unweighted av-
erage incidences are correlated in the inbred strain crosses because there are only two
common alleles per locus. In natural populations, multiple and rare alleles obscure this
correlation and make epistasis difficult to assess.
Similar to G×GNkx interactions, G×G×GNkx effect sizes increase with the severity of a
defect (Figure 3e). We calculated the G×G×GNkx contribution to the observed incidence
of a defect at each of the nine genotypes between every pair of significant and suggestive
loci (or the next most significant locus in the two cases where there is just one suggestive
locus). Statistically significant G×G×GNkx effect sizes vary between defects. AVSD effects
are larger than ASD and VSD effects. The relationship is not secondary to an underlying
correlation, such as between the observed incidence at a two-locus genotype and the
G×G×GNkx effect size or the severity of a defect.
3.4. Genetic Coadaptation between Interacting G×G×GNkx Loci Suppresses the Risk of Cardiac
Malformation
Patterns of G×G×GNkx effects suggest that positive selection promoted the coad-
aptation of interacting genes, as opposed to the elimination of intrinsically deleterious
alleles during the inbreeding of mouse strains. Among significant G×G×GNkx effects,
two-locus genotypes that are homozygous at both loci for alleles from the same inbred
strain or “syn-homozygous”, e.g., BB at both loci, are more likely to lower risk. Conversely,
anti-homozygous G×G×GNkx effects, e.g., homozygous FF at one locus and BB at the
other, are more likely to raise the risk. Heterozygosity at either locus is equally likely
to raise or lower risk (Figure 4a). Syn- and anti-homozygous G×G×GNkx interactions
can have major effects on the risk of a severe defect. For example, one anti-homozygous,
two-locus genotype accounts for 50% of all the AVSDs in the F×B intercross (Figure 3d).
The genotypes at either locus are not intrinsically deleterious because Nkx2-5 wild-type
mice, including littermates of affected mutants, do not develop AVSDs. Conversely, both
syn-homozygous genotypes at two loci in the A×B intercross effectively suppress AVSD
risk (Figure 3c). In general, no one- or two-locus genotype skews ASD or VSD risk as
extremely (Figure S3). Protective and deleterious effects of syn- and anti-homozygosity,
respectively, are associated with congruent effects at the other syn- and anti-homozygous
genotypes in a pair of interacting loci (Figure 4b–e). Internally consistent G×G×GNkx
effects suggest that selection for coadaptation was a recurrent event in the A/J, FVB/N,
and C57BL/6N inbred strains.




Figure 3. G×G×GNkx effects correlate with the severity of a heart defect. Representative plots depict 
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non-interacting loci. The ifference between the observed and expected incidences is the G×G×GNkx effect at a genotype.
Not all differenc s are significant. (a,b) ASD and VSD lo i mainly contribute to risk independ ntly, as indicated by similar
observed and expected incidences. Significant G×G×GNkx effects are small relative to the unweighted average of incidences
(UWA %, scale bars) across all nine genotypes. (c,d) Epistatic interactions between AVSD loci exert large G×G×GNkx effects.
Consider examples from two crosses. The syn-homozygous, AA–AA and BB–BB genotypes (blue *) in the A×B intercross
suppress risk significantly. In contrast, half of the AVSDs in the F×B intercross are associated with an anti-homozygous, Chr
5-Chr 16 BB–FF genotype (red *). (e) G×G×GNkx effect sizes correlate with defect severity (Kendall’s τ = 0.195, P = 0.0017).
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4. Discussion
Normal cardi c development is crucial for survival to reproductive age, but CHD
ph notypes exact vary ng costs on fitness. O e has to wonder whether the fact that
severe defects are rarer than mild ones ha n evolutionary basis [36]. In humans, highly
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penetrant, mostly de novo genetic abnormalities account for about one-third of all CHD
cases [7], but they are not necessarily associated with the most severe defects. In fact, ASDs
accounted for more than 10% of CHD cases in two large studies that examined the role of
de novo mutation by whole-exome sequencing [37,38]. We propose instead that the inverse
relationship is a consequence of the genetic architectures of individual phenotypes. The
present results offer novel perspectives on the nature of genetic risk in CHD and the origins
of mutational robustness in cardiac development.
Genetic heterogeneity and rare alleles obscure the biological significance of epistasis
in human diseases. In contrast, the power to detect genetic interactions is greater in inbred
strain crosses. Through such crosses, we show that the effects of pairwise and higher-order
epistasis correlate with the severity of a heart defect in Nkx2-5+/− mice. Other features
of the genetic architecture, such as the number of QTLs, do not correlate. The QTLs for
mild ASDs exert mainly small, additive effects on risk, while the QTLs for severe AVSDs
exert large, additive, and non-linear effects. The QTLs for moderately severe ventricular
septal defects have intermediate effects. Strikingly non-linear G×G×GNkx effects can either
suppress the risk of or account for a large fraction of AVSDs in the Nkx2-5+/− population.
A complex genetic model plausibly explains the inverse relationship between the
severity and incidence of a defect in humans. Whereas a modestly deleterious mutation
may be sufficient to cause a mild defect, additional genetic interactions may be necessary
to push a mutation carrier past the liability threshold for a severe defect, as observed in
the Nkx2-5+/− mouse model. Severe defects would thus be rarer because the multi-locus
genotypes that give rise to deleterious interactions are improbable. Consistent with this
model, a small study of non-syndromic AVSD found that among 34 persons who carried a
mutation of one of six AVSD genes (NIPBL, CHD7, CEP152, BMPR1A, ZFPM2, MDM4),
eight persons carried two or more mutations of the six genes [39]. Larger human studies
are necessary to validate an oligogenic model in which non-linear effects may have an
outsized role in severe CHD.
The model suggests a corollary: epistasis should matter less for strongly deleterious
mutations that place individuals near the liability threshold for a defect. To exert the same
phenotypic effect as a weak mutation and its contributing genetic interactions, a strong
mutation must either obstruct one critical pathway or perturb several simultaneously.
The dramatic effect of de novo mutations of histone-modifying genes, which regulate the
expression of multiple developmental genes, is consistent with the latter possibility [40].
The protective and deleterious effects of syn- and anti-homozygosity in G×G×GNkx
interactions are consistent with genetic coadaptation, a phenomenon first described by
Dobzhansky in 1948. In crosses of Drosophila isolated from geographically distant locales,
he noted “gene complexes” that conferred greater fitness when their alleles were from
the same, rather than different populations [41,42]. Increased fitness emerged from the
interaction between genotypes rather than their independent effects. Genetic coadaptation
is probably widespread but under-recognized. Known examples relate to growth under
different conditions in yeast [11], male fertility in Drosophila [12], body composition pheno-
types in mice [43], and vitamin D receptor and skin color gene coadaptation in humans [44].
An elegant example examined the genetic regulation of fasting blood glucose levels, a
diabetes-related trait. In a set of mouse crosses between chromosomal substitution strains,
one or two different chromosomes from the A/J strain were introduced into the C57BL/6J
background. Five interactions were discovered between pairs of different A/J chromo-
somes. Compared with the control C57BL/6J strain, mice that carried either one of the A/J
chromosomes in an interacting pair (e.g., chromosome 5 or 6) had elevated glucose levels.
Under an additive model, mice that carry both A/J chromosomes (e.g., chromosomes 5
and 6) should have higher glucose levels but actually had normal levels [45]. A/J and
C57BL/6J appear to have arrived at different genetic solutions to maintain normal blood
glucose levels.
Finally, the results suggest a rare example of selection for genetic robustness [18].
Whether robustness to mutation arises by selection or as an inherent consequence of an
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adapted trait has been a longstanding debate [17,46]. Depending upon the experimental
design, investigators lacked either the ancestral population to assess the pre-robust state or
the years required to detect selection for robustness in an evolving population [17]. Our
application of inbred strains circumvents these challenges. Inbreeding strongly selects for
fitness under genome-wide homozygosity. Unknown pressures appear to have selected
strain-specific genotypes at interacting loci that enhance the robustness of cardiac develop-
mental pathways to subsequent perturbation. The nkx2-5 mutation was probably not the
original selection pressure because there are many potential causes of CHD. Nevertheless,
outbreeding in the intercrosses produced individual variation in the robustness to the
Nkx2-5 mutation. Modifier locus genotypes permit us to observe the analog of pre- and
post-selected states in the same population. If humans similarly vary in the robustness
of cardiac developmental pathways, the genetic basis of CHD is a function not only of
deleterious variants but also of the degree of allelic compatibility between genes in the
individual.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/genes12091368/s1, Figure S1: Breeding scheme for inbred strain crosses, Figure S2: No
association between the number of loci detected or heritability with the severity of a defect, Figure S3:
Observed incidences of ASD, membranous and muscular VSD, and AVSD between every pair of
suggestive or significant modifier loci found in both crosses, Table S1: SNPs genotyped in the A×B
and F×B intercrosses, Table S2: Modifier loci by cross and defect.
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